Join us as we celebrate the 25th Anniversary of ACI’s Annual Flagship Conference on Drug & Medical Device Litigation.
ACI’s Drug and Medical Device Litigation is truly the only event of its kind to stand the test of time. This conference has united the greatest minds of the pharmaceutical and medical device product liability defense bar for the last quarter century. Designed for masters-level strategy sharing and bringing together hundreds of industry leaders each year from both in-house, private practice and government, this is the only forum at which to gain essential winning life sciences product liability litigation strategies.
CONFIRMED IN-HOUSE SPEAKERS
Engage and Interact with Leading In-House Counsel from Top Drug & Device Companies
Patricia A. Barbieri
SVP, General Counsel and Secretary, Legal and Corporate Affairs
Associate General Counsel, U.S. Litigation & Global Safety
Associate General Counsel
Beckton, Dickinson and Company
Howard M. Cyr
Assistant General Counsel
Senior Legal Counsel
Vice President, Head of Litigation & Investigations
Senior Assistant General Counsel
Amy Todd Klug
Associate General Counsel, Litigation & Corporate Operations, Legal Affairs
Daiichi Sankyo, Inc.
Veronica M. Lei
Assistant General Counsel – Litigation and Legal Compliance
Eli Lilly and Company
Associate General Counsel
Richard W. Silbert
VP, Chief Legal Strategist
Purdue Pharma L.P.
Matthew L. Stennes
Vice President, Chief Litigation & Investigations Counsel
Carly W. Stephani
Principal Litigation Counsel, Litigation & Global Investigations
Associate General Counsel
Nestle Health Science
Senior Vice President, Head of Global Litigation
Learn from Renowned Jurists
Honorable Karen K. Caldwell
U.S. District Court, E.D. of Kentucky
Judicial Panel on Multidistrict Litigation (JPML)
Honorable F. Dennis Saylor, IV
U.S. District Court, D. Massachusetts
Honorable John R. Tunheim
U.S. District Court, D. Minnesota
Honorable Eduardo C. Robreno
U.S. District Court, E.D. Pennsylvania
Honorable William F. Highberger
Superior Court Judge
Los Angeles County Superior Court
Honorable Rex Burlison
22nd Judicial Circuit of MO
What’s NEW for 2020?
Drug & Med Celebrates 25 Years
Industry leaders take a look back at the most significant legal and business developments that have impacted drug and device litigation in the last quarter century, as well as their implications and influence on future decisions, trends and strategies in this arena.
Covid-19’s Impact on Drug and Medical Device Litigation
A careful, comprehensive and timely analysis of the implications of Prep Act immunity on future drug and device litigation and an assessment of potential Covid-19 related MDLs.
Virtual Trial Practice Toolkit
Leading trial attorneys share strategies and best practices for conducting virtual/remote discovery, witness preparation, depositions, mediations, oral arguments and more.
Crisis Management Boot Camp
Lessons learned from Covid-19 on strengthening your response capabilities and minimizing business disruption in the face of a company or industry crisis.
MDL Case Study
Analysis of the unique nuances of three of 2020’s most significant MDLs – Hernia Mesh, Valsartan and Zantac.
Product Recall Do’s and Don’ts
Gain best practices for coordinating your team and minimizing damage to your company in the face of a nationwide product recall.
A View from the Bench — 2020 Edition
Judicial insights on how this year’s unprecedented events have impacted dockets, court functions, judicial proceedings and the JPML in general.
Special Focus Sessions
Advanced discussions surrounding this year’s changes to FDA approval processes as well as how current events are impacting juror mindsets, perceptions and verdicts in drug and device cases.
“5 Cs” of Successful In-House Counsel – Law Firm Partner Relationships
Join a unique conversation with our in-house counsel faculty designed to shed light on the expectations of in-house counsel from their law firm partners regarding cost, competency, communication, collaboration and culture.
High-Profile Prescription Drug and Medical Device Cases
In the last 10 years, nearly 300,000 product liability cases were filed in District Court, involving medical devices or pharmaceuticals products, including MDL-associated cases.
Join us this December to acquire firsthand insights from industry experts, and gain invaluable strategies to surmount the latest litigation challenges being faced by the drug and medical device products liability defense bar.
DEPUY ASR HIP
STRYKER REJUVENATE AND ABG II HIP IMPLANTS
Esteemed Judges & Government Enforcers
Companies on the Faculty & Advisory Board
Days of Networking
WHAT SETS US APART?
Your once-a-year opportunity to brainstorm with top in-house counsel including General Counsel and Chief Litigation Officers from diverse pharmaceutical and medical device companies and members of the products liability defense bar
Strengthen Relationships & Establish New Connections
Network and brainstorm with the Who’s Who of the products liability defense bar from leading litigators in the field as well as from over 25 in-house counsel responsible for handling litigation on behalf of the country’s top life sciences companies
The Most Relevant,
Join in high-level sessions focused on your most pressing challenges and opportunities
Federal and State Judges and
Gain a 360 degree view of products liability litigation from all the key stakeholders
Over 450 attended the 2019 event, including representatives from such leading life sciences companies as:
- American Regent
- Amneal Pharmaceuticals
- Bausch Health
- Becton, Dickinson and Company
- Bracco Diagnostics
- Bristol-Myers Squibb
- Cardinal Health
- Carestream Health
- Daiichi Sankyo
- Eli Lilly & Co.
- Endo Pharmaceuticals
- Johnson & Johnson
- Novo Nordisk
- Olympus Corporation
- PDL BioPharma
- Purdue Pharma
- Sage Therapeutics
- Stryker Corporation
- Teva Pharmaceuticals
- Zimmer Biomet
- W.L. Gore
“There is no better forum for leading edge thinking on today’s most pressing drug and med litigation challenges.”
“I enjoy attending ACI’s Drug and Med because of the quality presentations, and the interaction with the lawyers and clients that I’ve had the opportunity to work with for so many years.”
“The ACI Drug and Med conference is a great opportunity to connect with other members of the products liability bar and get real-time and real-world information about mass tort litigation throughout the country.”
“I attend ACI’s Drug and Med because it’s an opportunity to meet and reconnect with colleagues who are both my peers at other law firms and clients. I found the presentation on attorney advertising to be very helpful.”
“Attending this conference is an opportunity to see both one’s clients as well as counsel from other firms with whom one works on a regular basis usually via email or phone but rarely in person, so you get to see these people at least once a year which is important.”
“ACI’s Drug and Med conference is informative and attracts top professionals year after year, giving you the opportunity to develop lasting professional and personal relationships.”
WHO YOU WILL MEET
In-house counsel for:
Medical device companies
Health care organizations
Attorneys practicing in:
Drug and medical devices
Complex and multidistrict litigation healthcare
We hope to see you in December! Register early and save with the Early Bird discount today!Register now
ACI’s Global Series of Life Sciences Conferences Bring together key sector stakeholders from around the globe to explore the most important trends impacting the many industries including pharmaceutical, biotechnology, medical device/diagnostic, and FDA-regulated consumer products. Our events cover every facet of legal and business relevance as well as controversy. Learn More